News from institute for research in immunology and cancer (iric) of the université de montréal A wide array of domestic and global news stories; news topics include politics/government, business, technology, religion, sports/entertainment, science/nature, and health/lifestyle.

Latest

Jun 04, 2019, 12:56 ET $10M awarded to IRIC for the development of new cancer-fighting drugs and immunotherapies

MONTREAL, June 4, 2019 /CNW Telbec/ - The Institute for Research in Immunology and Cancer (IRIC) of the Université de Montréal (UdeM) has been awarded a 10-million dollar grant from the government of ...


May 31, 2019, 08:22 ET 62nd Annual Conference of the Canadian Society for Molecular Biosciences (CSMB) at IRIC

MONTREAL, May 31, 2019 /CNW Telbec/ - On the occasion of the 62nd Annual Conference of the CSMB, the Institute for Research in Immunology and Cancer (IRIC) of the Université de Montréal is delighted...


May 30, 2019, 14:04 ET Audacious 2019: $1M raised to support IRIC's research efforts to vanquish cancer

MONTREAL, May 30, 2019 /CNW Telbec/ - Close to 400 guests were on hand at the Gare Windsor for the 6th edition of the Audacious fundraising event, organized by the Institute for Research in...


Apr 18, 2019, 08:23 ET The Institute for Research in Immunology and Cancer takes part in the first edition of EFFERVESCENCE

MONTREAL, April 18, 2019 /CNW Telbec/ - The Institute for Research in Immunology and Cancer (IRIC) of the Université de Montréal is proud to contribute to the first edition of EFFERVESCENCE, a major...


Feb 01, 2019, 08:37 ET Media invitation - World Cancer Day: the IRIC is setting up two scientific outreach events

MONTREAL, Feb. 1, 2019 /CNW Telbec/ - On the occasion of World Cancer Day (February 4), the Institute for Research in Immunology and Cancer (IRIC) of the Université de Montréal is organizing two...


Sep 11, 2018, 08:08 ET Dr. Guy Sauvageau elected to the Academy of Science of the Royal Society of Canada

MONTREAL, Sept. 11, 2018 /CNW Telbec/ - Dr. Guy Sauvageau, Principal Investigator at the Institute for Research in Immunology and Cancer (IRIC) of the Université de Montréal and hematologist at the...


Jun 27, 2018, 09:03 ET UM171 Molecule: Completion of Phase I/II clinical trial for the treatment of blood cancer patients

MONTREAL, June 27, 2018 /CNW Telbec/ - On June 12, the Institute for Research in Immunology and Cancer (IRIC) of the Université de Montréal celebrated 10 years of activity for its medicinal chemistry ...


Jun 05, 2018, 11:05 ET The Institute for Research in Immunology and Cancer receives funding support from AbbVie for its work involving acute myeloid leukemia, paving the way to developing a cancer vaccine

MONTREAL, June 5, 2018 /CNW Telbec/ - The Institute for Research in Immunology and Cancer (IRIC) of the Université de Montréal is proud to announce that it has received funding support from AbbVie, a ...